Home Clade Therapeutics

Clade Therapeutics

acquired
Series A
Cell Therapy Developer

Basic Information

Clade Therapeutics' mission is to discover and deliver the next generation of cellular medicines to improve the lives of patients in need. Our platform technology "cloaks" human pluripotent stem cells and their adult derivatives, enabling the development of immune-compatible cell transplantation therapies. Led by a world-class team of company builders and scientific innovators, Clade possesses unparalleled expertise in generating stem cell-derived adult T, NK, and B cells.
Clade Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
less than 15 people
January 01, 2020
contact.us@cladetx.com